The largest database of trusted experimental protocols
> Disorders > Disease or Syndrome > Hypersomnia

Hypersomnia

Hypersomnia is a sleep disorder characterized by excessive daytime sleepiness, despite adequate nighttime sleep.
Individuals with hypersomnia may experience difficulty staying awake during the day and may fall asleep unintentionally, even during activites.
This condition can have a significant impact on daily functioning and quality of life.
Causes of hypersomnia may include narcolepsy, sleep apnea, medications, or underlying medical conditions.
Effective management often involves a combination of lifestyle modifications, medications, and treatment of any underlying causes.
Accurate diagnosis and personalized treatment plan are crucial for managing hypersomnia and improving patients' outcomes.
PubCompare.ai's AI-powered platform can help researchers optimize their hypersomnia studyes by easily locating the best research protocols from scientific literature, pre-prits, and patents, enhancing reproducibility and efficacy.

Most cited protocols related to «Hypersomnia»

Item response data for the SD and SRI item banks were obtained from an internet (YouGov Polimetrix) sample and a clinical sample at the University of Pittsburgh Medical Center. YouGov Polimetrix is a national, web-based polling firm based in Palo Alto, CA. YouGov Polimetrix customized the sample to include individuals with various health conditions (Polimetrix, 2006 ).
The YouGov Polimetrix sample consisted of 1,993 respondents (41% women, 11% Hispanic, 16% minority, and mean age [S.D.] 52 [15.9]), including 1,259 adults from the general population without self-reported sleep problems, and 734 with self-reported sleep problems. Sleep problems were identified by self report with 4 branching questions: “Have you ever been told by a doctor or health professional that you have a sleep disorder?” “What type of sleep disorder (with 13 options)?” “Has your sleep disorder been treated?” and “Did the treatment help you?”. In order to have adequate observations of each response category for each item, especially for response categories indicating high severity, a separate clinical sample was added to enrich the Polimetrix sample and included 259 patients with sleep problems obtained from sleep medicine clinics in psychiatry and general medicine (61% women, 2% Hispanic, 30% minority, mean age [S.D.] 44 [13.8]). In aggregate, the Polimetrix sample of 1, 993 participants plus the clinical sample of 259 participants, the final pooled sample included 2, 252 participants. For a detailed description of this pooled sample, see Buysse et al. (2010) (link).
Publication 2011
Adult Dyssomnias Health Care Professionals Hispanics Hypersomnia Minority Groups Patients Physicians Sleep Disorders Woman

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2013
Anhedonia Concept Formation Depressive Symptoms Fatigue Guilt Hypersomnia Mood Screening Sleeplessness

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2012
Cells EPOCH protocol Hypersomnia Interneurons Neurons Pyramidal Cells Sleep Sleep, REM Strains

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Anhedonia Depressive Symptoms Fatigue Guilt Hypersomnia Mood Sleeplessness
Essentially, a sleep detection method is a function that classifies the sleep state of a patient. Most sleep detection methods such as wrist actigraphy or mobile apps consider a binary function, where the state can be classified as Awake/Sleep. More sophisticated methods consider a ternary function: Awake/NREM/REM. And, finally, the most advanced methods, such as polysomnography—often used as the gold standard—consider a quinquenary function: Awake/N1/N2/N3/REM. Hence, any method can produce a two-dimensional chart where the X-axis is Time, and the Y-axis is the State of the Patient. In the particular case of polysomnography, the Y-axis has five possible values; thus, it can determine the sleep stage of the patient at any time, and study the transitions occurring between the states. Of course, a sleep study such as a polysomnography often produces much more complementary information that can be used, e.g., to diagnose sleep diseases. Among the information reported by a polysomnography we find oxygen saturations, limb movements, apneas, respiratory events by body position, etc. The interested reader is referred to Robertson, Marshall & Carno (2014) , Pandi-Perumal, Spence & BaHammam (2014) and Armon et al. (2016) for information about sleep study reports and their interpretation and usage.
The information that is common to the majority of sleep detection methods is the one that refers to a binary state classification (i.e., Awake/Sleep), because this is achieved by the basic methods, and subsumed by the advanced methods. Table 1 defines the basic parameters that can be collected by a binary state classification method. In grey, we show the primary data that should be collected by the sleep detection device and, in white, we show the most important parameters that can be derived from the primary data.
These parameters are particularly useful to determine the kind of sleep of patients, and each single parameter is relevant for a different sleep disorder or disease. For instance, the sleep onset, sleep latency, and total sleep time are essential to diagnose patients with insomnia. Similarly, an excess in the awakening and arousal indices suggests increased sleep fragmentation. In addition to the number of sleep states that they are able to detect, a sleep detection method can be classified according to other functional and operational characteristics, such as their underlying technology, which in turn directly affects their precision and validity.
In Fig. 2, we present a taxonomy of sleep detection methods. They all can be classified into two main groups according to whether they need medical assistance (Medical Assistance) or not (Self-Assessment). In this respect, there are methods that have been classified as not requiring medical assistance, such as Questionnaires and Sleep Diaries, even though their interpretation should be normally done by a professional. However, in the current state of the art there are many systems such as mobile apps that provide custom sleep questionnaires and produce reports without medical assistance. Hence, they are classified as Self-Assessment. They both deserve a deep discussion and will be explained separately in ‘Medical Assistance Methods’ and ‘Self-Assessment Methods’, respectively.
Self-Assessment methods include subjective methods such as questionnaires and sleep diaries (the figure lists some instances), and objective methods based on hardware sensors, which in turn can be classified as Contact devices or Contactless devices, depending on whether they need to be in contact with the patient’s body during sleep. Those devices that are based on the echo produced by signals can be further classified into Sonar, Radar, and Lidar devices. All of them will be explained in a dedicated section.
Full text: Click here
Publication 2018
Actigraphy Apnea Arousal Diagnosis ECHO protocol Epistropheus Gold Human Body Hypersomnia Medical Devices Movement Oxygen Saturation Patients Polysomnography Respiratory Rate Self-Assessment Sleep Sleep Disorders Sleep Fragmentation Sleeplessness Sleep Stages Wrist

Most recents protocols related to «Hypersomnia»

The primary outcome of interest was hypertension (coded as yes/no). Hypertension was defined as systolic blood pressure (SBP) of 140 mmHg or more, or diastolic blood pressure (DBP) of 90 mmHg or above, or currently on medication based on JNC 7 classification (Chobanian et al., 2003 (link)), and SBP of 130 mmHg or more, or DBP of 80 mmHg or above, or currently on medication as per guidelines provided by the 2017 American Heart Association (AHA) (Whelton et al., 2018 (link)).
Socio-demographic characteristics: sex, age, educational status, marital status, occupation, religion, household size, and wealth index; Anthropometric and behavioural factors: body mass index, abdominal obesity, waist-to-hip ratio, smoking status, alcohol consumption, khat chewing, physical activity level, and fruit and vegetable intakes; Other factors: diabetes mellitus, stress score, sleep duration, and quality, excessive sleepiness, snoring, and family history of hypertension were the independent variables that were used to explain the dependent variable.
Full text: Click here
Publication 2023
Catha edulis Diabetes Mellitus Fruit High Blood Pressures Households Hypersomnia Index, Body Mass Pharmaceutical Preparations Pressure, Diastolic Systolic Pressure Vegetables Waist-Hip Ratio
We administered well-validated and translated assessments. Arabic versions of these tools have been used in epileptic samples, as well as patients with diabetes, hypertension, cancer, dermatological concerns, and healthy adults in Saudi Arabia.16 (link),22 (link)-27
The PSQI was administered to evaluate the sleep habits of all participants during the past month. Scores were an aggregate of seven components, each scored 0 (no difficulty) to 3 (severe difficulty). Total scores ranged 0-21, with higher scores 5 or more indicating poorer or worse quality of sleep.
The ISI comprised seven questions, which were summed to obtain a total score. Participants with scores of (0-7, 8-14, 15-21, and 22-28) were considered to have “no clinically significant insomnia”, “subthreshold insomnia”, “moderate clinical insomnia”, and “severe clinical insomnia”, respectively.
The ESS was used to measure subjective sleepiness. The test comprises eight situations in which we rate the patient’s tendency to become sleepy on a scale of 0 (no chance of dozing) to 3 (high chance of dozing). The participant’s total score is a sum of the eight questions, and participants are categorized into one of four categories: unlikely abnormal sleepiness (score 0-7), average DTS (score 8-9), excessive sleepiness that may require medical attention (score 10-15), and excessive sleepiness and that requires medical attention (score 16-24).
In addition to these 3 questionnaires, sociodemographic and clinical characteristics were collected, including gender, education level, type of epilepsy, presence of nocturnal seizures, neuroimaging findings, epilepsy duration, age of onset, and number of antiepileptics medications.
Publication 2023
Adult Antiepileptic Agents Attention Diabetes Mellitus Epilepsy Gender High Blood Pressures Hypersomnia Malignant Neoplasms Patients Seizures Sleeplessness Somnolence
To adjust for comorbidities (e.g., cardiac disease, cerebrovascular disease, renal failure, liver diseases, malignancies, and diabetes mellitus), Quan’s algorithm of Charlson Comorbidity Index (CCI) [29 (link)] was used, which is known to predict mortality adequately [30 (link)]. Given that the original CCI calculation includes dementia diagnosis, we calculated CCI except for dementia because it was our primary outcome variable. In addition to CCI, a history of schizophrenia, mood disorders (depression and bipolar disorder), anxiety disorders, Parkinson’s disease, iron deficiency anemia, and sleep disorders (insomnia, hypersomnia, sleep-related breathing disorder, narcolepsy, sleepwalking, sleep terror, and nightmare) were considered as covariates.
Full text: Click here
Publication 2023
Anxiety Disorders Bipolar Disorder Cerebrovascular Disorders Dementia Diabetes Mellitus Diagnosis Heart Diseases Hypersomnia Iron Deficiency Anemia Kidney Failure Liver Diseases Malignant Neoplasms Mood Disorders Narcolepsy Nightmares Night Terrors Schizophrenia Sleep Disorders Sleeplessness
As part of the baseline questionnaire, participants reported five sleep characteristics, based on which we further identified five healthy phenotypes, including no usual insomnia complaints, adequate sleep duration (7 to < 9 h/day), no snoring, morning chronotype, and no frequent daytime sleepiness [9 (link)]. We scored participants from 0 to 5, according to the count of healthy characteristics and categorized them into three groups: “healthy sleep” (≥ 4 composite sleep score); “intermediate sleep” (2 or 3 score); and “poor sleep” (≤ 1 score). This categorization has been proven to distinguish different CVD risk profiles, and the simple addition approach showed a similar predictive power to a weighted score [9 (link)]. The original questions and options were provided in Additional file 1: Table S2. These definitions and scores have shown excellent convergent validity with CVD incidence and mortality [8 (link), 9 (link)].
We identified recent clinical sleep disorder events (2 years before enrolment) based on inpatient admissions, primary care clinical events, and sleep disorder-specific prescriptions (BNF Chapter 4 Sect. 1: hypnotics and anxiolytics). Modified from the definition provided by the American Sleep Association and American Academy of Sleep Medicine [16 , 17 (link)], we distinguished five different sleep disorders, including insomnia, hypersomnia, sleep-related breathing disorders, circadian rhythm sleep disorders, and parasomnias (including sleep-related bruxism). In addition, we grouped hypersomnia, circadian rhythm sleep disorders, parasomnias, non-specific sleep disorders (e.g., “poor sleep pattern”), and sleep medication prescriptions without a corresponding clinical event into “other sleep disorders.” We provided detailed codes for each classification system in Additional file 1: Table S3-5. Since the clinical diagnosis of sleep disorders mainly refers to more than one self-reported sleep characteristic, we did not further integrate both self-reported and clinically unhealthy sleep.
Full text: Click here
Publication 2023
Anti-Anxiety Agents Chronotype Diagnosis GZMB protein, human Hypersomnia Hypnotics Inpatient Parasomnia Pharmaceutical Preparations Phenotype Prescriptions Primary Health Care Sleep Sleep-Related Bruxism Sleep Disorders Sleep Disorders, Circadian Rhythm Sleeplessness
Post-sleep questionnaires were completed in the morning after an overnight PSG. The patients were asked to subjectively assess their TST, sleep onset latency, and WASO in the last night. Sleep state misperception was quantified by subtracting the objective PSG-measured TST from the subjective sleep duration obtained by the post-sleep questionnaire.9 (link) Thus, negative values indicated that the subjective response was an underestimate, while positive values indicated that the subjective response was an overestimate. Using the cutoff values of ± 60 minutes of sleep state misperception, the categories with normal, underestimated, and overestimated sleep state perception were defined as differences of −60 to +60 minutes, < −60 minutes, and > +60 minutes, respectively.9 (link)
Publication 2023
Hypersomnia Patients Sleep Sleep State Misperception

Top products related to «Hypersomnia»

Sourced in United States, United Kingdom, Italy, Belgium, Germany
The Lunar Prodigy Advance is a dual-energy X-ray absorptiometry (DXA) system designed for bone mineral density (BMD) assessment. It utilizes low-dose X-rays to measure the bone density of the spine, hip, and other skeletal sites. The system provides precise and reproducible measurements to aid in the diagnosis and management of osteoporosis and other bone-related conditions.
Sourced in United States
The MiniMuffs are a compact and portable noise-reduction system designed for use in medical and laboratory settings. The product's core function is to provide a controlled acoustic environment to protect sensitive hearing during procedures or examinations.
Sourced in Germany, United Kingdom
The Tim Trio system is a laboratory equipment product manufactured by Siemens. It is a compact and versatile device designed for a range of laboratory applications. The Tim Trio system provides precise temperature control and monitoring functionality. Its core function is to enable accurate and reliable temperature management for various laboratory processes.
The Automated SD cylindrical apparatus is a lab equipment designed for conducting standardized testing procedures. It automates the process of performing dimensional measurements on cylindrical samples. The device features automated control and data collection capabilities to ensure consistent and reliable results.
Sourced in Germany, United States
The 3T Tim Trio is a magnetic resonance imaging (MRI) system developed by Siemens. It operates at a magnetic field strength of 3 tesla, which allows for high-resolution imaging. The system is designed to capture detailed images of the human body for diagnostic and research purposes.
Sourced in Germany, United States, United Kingdom, China
The Tim Trio is a versatile laboratory equipment that serves as a temperature-controlled magnetic stirrer. It features three independent stirring positions, allowing simultaneous operation of multiple samples. The device maintains a consistent temperature range to ensure accurate and reliable results during experimental procedures.
Sourced in Germany
The Avanto 1.5T scanner is a magnetic resonance imaging (MRI) system produced by Siemens. It is designed to perform high-quality diagnostic imaging of the human body. The Avanto 1.5T scanner utilizes a 1.5 tesla superconducting magnet to generate the magnetic field necessary for MRI imaging.
Sourced in United States, Austria, Japan, Cameroon
SAS statistical software is a comprehensive data analysis and visualization tool. It provides a wide range of statistical procedures and analytical capabilities for managing, analyzing, and presenting data. The software is designed to handle large and complex datasets, allowing users to perform advanced statistical modeling, regression analysis, and data mining tasks. The core function of the SAS statistical software is to enable users to extract insights and make data-driven decisions.
Sourced in United States, Japan, United Kingdom, Belgium, Austria, Australia, Spain
SPSS is a comprehensive statistical software package that enables data analysis, data management, and data visualization. It provides a wide range of statistical techniques, including descriptive statistics, bivariate analysis, predictive analytics, and advanced modeling. SPSS is designed to help users efficiently manage and analyze large datasets, making it a valuable tool for researchers, statisticians, and data analysts.
Sourced in United States
Sertraline is a pharmaceutical laboratory equipment used in the production and analysis of the active pharmaceutical ingredient sertraline. It is a specialized device designed to facilitate the manufacturing, testing, and quality control processes associated with the development of the sertraline drug product.

More about "Hypersomnia"

Hypersomnia is a sleep disorder characterized by excessive daytime sleepiness, despite adequate nighttime sleep.
Individuals with hypersomnolence may experience difficulty staying awake during the day and may unintentionally fall asleep, even during activities.
This condition can significantly impact daily functioning and quality of life.
Causes of excessive sleepiness may include narcolepsy, sleep apnea, medications, or underlying medical conditions.
Effective management often involves a combination of lifestyle modifications, medications, and treatment of any underlying causes.
Accurate diagnosis and personalized treatment plans are crucial for managing hypersomnolence and improving patient outcomes.
Researchers can optimize their hypersomnia studies by utilizing PubCompare.ai's AI-powered platform, which helps locate the best research protocols from scientific literature, pre-prints, and patents, enhancing reproducibility and efficacy.
The Lunar Prodigy Advance, MiniMuffs, and Tim Trio system can be used in hypersomnia research, along with the Automated SD cylindrical apparatus and 3T Tim Trio scanner.
SAS and SPSS statistical software can aid in data analysis.
Sertraline, a selective serotonin reuptake inhibitor (SSRI), may be used in the treatment of hypersomnia in some cases.
By incorporating these tools and techniques, researchers can optimize their hypersomnia studies and deliver more effective and impactful results.